Table 2 Interleukin 32 levels according to patient characteristics
From: Assessment of interleukin 32 as a novel biomarker for non-alcoholic fatty liver disease
| Â | Interleukin 32 concentration (pg/mL) | p value | ||
|---|---|---|---|---|
n | Median (IQR) | |||
Sex | Male | 13 | 76 (49.75–99.5) | 0.942 |
Female | 27 | 76 (40–120) | ||
Special habits | Non-smoker | 30 | 76 (39.37–123.75) | 0.766 |
Smoker | 10 | 76 (65.62–108.37) | ||
Hypertension | No | 25 | 82 (56.75–13) | 0.678 |
Yes | 15 | 69 (45.5–191.87) | ||
Fatty liver index | Indeterminate | 7 | 76 (67.5–200.5) | 0.630 |
High | 33 | 76 (38.75–105) | ||
NAFLD fibrosis score | F0–F2 | 7 | 76 (76–200.5) | 0.318 |
Indeterminate | 33 | 76 (38.75–102.25) | ||